Efficacy and Safety of Transarterial Chemoembolization Plus Lenvatinib with or Without Tislelizumab as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
-
Published:2024-08
Issue:
Volume:Volume 11
Page:1607-1622
-
ISSN:2253-5969
-
Container-title:Journal of Hepatocellular Carcinoma
-
language:en
-
Short-container-title:JHC
Author:
Jiang JiayunORCID,
Zhang Hui,
Lai Jiejuan,
Zhang Shiyu,
Ou Yanjiao,
Fu YuORCID,
Zhang Leida
Publisher
Informa UK Limited